Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph C Presti

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Urology|March 27, 2012
Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH databaseRoberto L Muller, Joseph C Presti, William J Aronson, et al.
The Journal of Urology|January 13, 2006
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detectionStephen J Freedland, Elizabeth A Platz, Joseph C Presti, et al.
The Journal of Urology|September 18, 2009
Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
BJU International|September 10, 2008
The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital DatabaseRyan S Turley, Martha K Terris, Christopher J Kane, et al.
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
The Journal of Urology|August 19, 2007
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH databaseCharles D Scales, Joseph C Presti, Christopher J Kane, et al.
BJU International|November 22, 2008
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?Florian R Schroeck, William J Aronson, Joseph C Presti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH databaseLionel L Bañez, Martha K Terris, William J Aronson, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Urology|March 27, 2012
Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH databaseRoberto L Muller, Joseph C Presti, William J Aronson, et al.
The Journal of Urology|January 13, 2006
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detectionStephen J Freedland, Elizabeth A Platz, Joseph C Presti, et al.
The Journal of Urology|September 18, 2009
Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
BJU International|September 10, 2008
The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital DatabaseRyan S Turley, Martha K Terris, Christopher J Kane, et al.
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
The Journal of Urology|August 19, 2007
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH databaseCharles D Scales, Joseph C Presti, Christopher J Kane, et al.
BJU International|November 22, 2008
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?Florian R Schroeck, William J Aronson, Joseph C Presti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH databaseLionel L Bañez, Martha K Terris, William J Aronson, et al.
Pageof 12